161 related articles for article (PubMed ID: 23878005)
1. Magnesium sulfate potentiates effect of DigiFab on marinobufagenin-induced Na/K-ATPase inhibition.
Zazerskaya IE; Ishkaraeva VV; Frolova EV; Solodovnikova NG; Grigorova YN; David Adair C; Fedorova OV; Bagrov AY
Am J Hypertens; 2013 Nov; 26(11):1269-72. PubMed ID: 23878005
[TBL] [Abstract][Full Text] [Related]
2. DigiFab interacts with endogenous cardiotonic steroids and reverses preeclampsia-induced Na/K-ATPase inhibition.
Ishkaraeva-Yakovleva VV; Fedorova OV; Solodovnikova NG; Frolova EV; Bzhelyansky AM; Emelyanov IV; Adair CD; Zazerskaya IE; Bagrov AY
Reprod Sci; 2012 Dec; 19(12):1260-7. PubMed ID: 22649120
[TBL] [Abstract][Full Text] [Related]
3. Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia.
Fedorova OV; Ishkaraeva VV; Grigorova YN; Reznik VA; Kolodkin NI; Zazerskaya IE; Zernetkina V; Agalakova NI; Tapilskaya NI; Adair CD; Lakatta EG; Bagrov AY
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30104471
[TBL] [Abstract][Full Text] [Related]
4. Endogenous Na/K-ATPase inhibitors in patients with preeclampsia.
Averina IV; Tapilskaya NI; Reznik VA; Frolova EV; Fedorova OV; Lakatta EG; Bagrov AY
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):19-23. PubMed ID: 17535731
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension.
Fedorova OV; Simbirtsev AS; Kolodkin NI; Kotov AY; Agalakova NI; Kashkin VA; Tapilskaya NI; Bzhelyansky A; Reznik VA; Frolova EV; Nikitina ER; Budny GV; Longo DL; Lakatta EG; Bagrov AY
J Hypertens; 2008 Dec; 26(12):2414-25. PubMed ID: 19008721
[TBL] [Abstract][Full Text] [Related]
6. Endogenous cardiotonic steroids in chronic renal failure.
Kolmakova EV; Haller ST; Kennedy DJ; Isachkina AN; Budny GV; Frolova EV; Piecha G; Nikitina ER; Malhotra D; Fedorova OV; Shapiro JI; Bagrov AY
Nephrol Dial Transplant; 2011 Sep; 26(9):2912-9. PubMed ID: 21292813
[TBL] [Abstract][Full Text] [Related]
7. Endogenous marinobufagenin-like immunoreactive factor and Na+, K+ ATPase inhibition during voluntary hypoventilation.
Bagrov AY; Fedorova OV; Austin-Lane JL; Dmitrieva RI; Anderson DE
Hypertension; 1995 Nov; 26(5):781-8. PubMed ID: 7591018
[TBL] [Abstract][Full Text] [Related]
8. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
[TBL] [Abstract][Full Text] [Related]
9. Canrenone Restores Vasorelaxation Impaired by Marinobufagenin in Human Preeclampsia.
Agalakova NI; Grigorova YN; Ershov IA; Reznik VA; Mikhailova EV; Nadei OV; Samuilovskaya L; Romanova LA; Adair CD; Romanova IV; Bagrov AY
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328757
[TBL] [Abstract][Full Text] [Related]
10. Antibody against Na/K-ATPase Inhibitor Lowers Blood Pressure and Increases Vascular Fli1 in Experimental Preeclampsia.
Agalakova NI; Reznik VA; Nadei OV; Ershov IA; Rassokha OS; Vasyutina ML; Ivanov DO; Adair CD; Galagudza MM; Bagrov AY
Am J Hypertens; 2020 May; 33(6):514-519. PubMed ID: 31713584
[TBL] [Abstract][Full Text] [Related]
11. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
Bagrov AY; Dmitrieva RI; Dorofeeva NA; Fedorova OV; Lopatin DA; Lakatta EG; Droy-Lefaix MT
J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
[TBL] [Abstract][Full Text] [Related]
12. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta.
Fedorova OV; Agalakova NI; Morrell CH; Lakatta EG; Bagrov AY
Hypertension; 2006 Dec; 48(6):1160-8. PubMed ID: 17043158
[TBL] [Abstract][Full Text] [Related]
13. Plasma marinobufagenin-like and ouabain-like immunoreactivity in adrenocorticotropin-treated rats.
Fedorova OV; Anderson DE; Bagrov AY
Am J Hypertens; 1998 Jul; 11(7):796-802. PubMed ID: 9683040
[TBL] [Abstract][Full Text] [Related]
14. Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists.
Fedorova OV; Emelianov IV; Bagrov KA; Grigorova YN; Wei W; Juhasz O; Frolova EV; Marshall CA; Lakatta EG; Konradi AO; Bagrov AY
J Hypertens; 2015 Aug; 33(8):1602-10. PubMed ID: 26136067
[TBL] [Abstract][Full Text] [Related]
15. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
Bagrov AY; Fedorova OV
J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
[TBL] [Abstract][Full Text] [Related]
16. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY
Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
[TBL] [Abstract][Full Text] [Related]
17. Interaction of Digibind with endogenous cardiotonic steroids from preeclamptic placentae.
Fedorova OV; Tapilskaya NI; Bzhelyansky AM; Frolova EV; Nikitina ER; Reznik VA; Kashkin VA; Bagrov AY
J Hypertens; 2010 Feb; 28(2):361-6. PubMed ID: 19927009
[TBL] [Abstract][Full Text] [Related]
18. Preeclampsia: Cardiotonic Steroids, Fibrosis, Fli1 and Hint to Carcinogenesis.
Agalakova NI; Kolodkin NI; Adair CD; Trashkov AP; Bagrov AY
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669287
[TBL] [Abstract][Full Text] [Related]
19. Low-dose cardiotonic steroids increase sodium-potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia.
Oselkin M; Tian D; Bergold PJ
Neurosci Lett; 2010 Apr; 473(2):67-71. PubMed ID: 19822191
[TBL] [Abstract][Full Text] [Related]
20. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.
Bagrov AYa ; Fedorova OV; Maslova MN; Roukoyatkina NI; Ukhanova MV; Zhabko EP
Cardiovasc Res; 1991 May; 25(5):371-7. PubMed ID: 1649699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
